Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 3
|
| Page
3 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
Drug reverses bone loss in men with prostate cancer during the first year of treatment
A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy. view more (2006-02-27)
New study gives further hope that vitamin D can fight breast cancer
Vitamin D may help curb breast cancer progression, according to a study published today in the Journal of Clinical Pathology. view more (2006-10-17)
Younger men with advanced prostate cancer have shorter survival times
While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. view more (2009-05-22)
Periods worsen irritable bowel symptoms
Having a period significantly worsens symptoms of irritable bowel syndrome (IBS) and lowers pain thresholds, finds research in Gut. view more (2002-03-11)
A surprise 'spark' for pre-cancerous colon polyps
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah studied the events leading to colon cancer and found that an unexpected protein serves as the "spark" that triggers formation of colon polyps, the precursors to cancerous tumors. view more (2009-05-15)
Regular, long-term aspirin use reduces risk of colorectal cancer
The use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk associated with colorectal cancer, according to a study published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. view more (2008-01-23)
Early results indicate radiofreqency ablation useful in treating ovarian cancer metastasis
Percutaneous radiofrequency ablation, a procedure that uses a high frequency electric current to kill tumor cells, is effective in achieving local control in selected patients with metastasis from ovarian cancer. view more (2006-09-29)
OHSU Cancer Institute researchers study breathing during radiation
Oregon Health & Science University researchers have determined exactly how much breathing affects prostate movement during radiation treatment. view more (2008-09-24)
Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
Primary colorectal signet ring cell carcinoma is a rare but distinctive malignancy of the large bowel. More than 96% of signet ring cell carcinomas arise in the stomach, with the rest arising from other primary organs. view more (2008-05-21)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival
According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy... view more... (2006-01-05)
OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation. view more (2008-04-23)
Managing Colorectal Cancers In The NHS
How best to detect and manage bowel cancer is the subject of the latest issue of EFFECTIVE HEALTH CARE. Colorectal (bowel) cancer is the second most common cause of cancer death in England and Wales. Early detection and good management result in improved survival rates. Improvements have been made in the provision of services and treatment of... view more... (2004-06-28)
Patients' pretreatment quality of life can predict overall lung cancer survival
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that an individual's quality of life prior to treatment can help predict the overall survival of patients with advanced stage non-small cell lung cancer (NSCLC). view more (2009-09-03)
Trial Supports Use of Marker to Predict How Pancreatic Cancer Patients Do After Surgery, Jefferson Surgeon Finds
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation. view more (2007-06-25)
Surgery remans an option for advanced lung cancer
In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery. view more (2009-07-27)
Who gets cancer treatment, and who completes it?
Cancer treatment is now very effective in many cases, yet not all patients with cancer are referred and not all complete their treatment programme. This has puzzled cancer specialists who have wondered if psychological factors might influence their decision and has led to research carried out by Dr Stan Lindsay from the Institute of Psychiatry in... view more... (2002-11-13)
U.S. trial shows no early mortality benefit from annual prostate cancer screening
The prostate cancer screening tests that have become an annual ritual for many men don't appear to reduce deaths from the disease among those with a limited life-expectancy, according to early results of a major U.S. study involving 75,000 men. view more (2009-03-19)
Smokers with advanced colon cancer may face higher odds of disease recurrence
People with advanced colon cancer who have smoked cigarettes or used other tobacco products for many years may have an increased risk that their colon cancer will return, according to research by Dana-Farber Cancer Institute scientists to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, in... view more... (2008-05-30)
Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
According to a new study, the drug sunitinib malate (Sutent®) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). view more (2006-06-05)
Combined Treatment Approach Increases Survival In Prostate Cancer
New study shows combination of radiotherapy and hormone therapy extends life expectancy. view more (2005-04-04)
|
|
| Page
3 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
